RBI August 2026 Policy: Repo Rate Held at 5.25%, but the Message Was Bigger
RBI kept the repo rate unchanged at 5.25% in August 2026. Here’s what the policy signals on inflation, growth, the rupee, FCNR(B) inflows and future rate moves.
Read FullArchive of all the blogs posted
Showing 12 articles this page
RBI kept the repo rate unchanged at 5.25% in August 2026. Here’s what the policy signals on inflation, growth, the rupee, FCNR(B) inflows and future rate moves.
Read Full
Situational Awareness lost about 67% in July 2026 after leveraged AI positions triggered margin pressure and forced selling. Here is what investors can learn.
Read Full
FPIs returned as net buyers of Indian equities in July 2026. See which sectors attracted inflows, where selling continued, and whether the comeback can last.
Read Full
India’s Dedicated Freight Corridors could shift long-haul cargo to rail while changing demand for HCVs, MCVs, LCVs, tractor-trailers and specialised commercial vehicles.
Read Full
The Federal Reserve held rates at 3.50%–3.75% despite persistent inflation and three dissenting votes. Understand Kevin Warsh’s interest rate dilemma and its impact on markets.
Read Full
India imports nearly 90% of its crude oil, yet exports diesel worldwide. See how refining scale, Jamnagar and global shortages created this advantage.
Read Full
Why did Nifty IT rally nearly 16% in July 2026? See how earnings, AI revenue, deal wins and global rotation shaped the rebound in Indian IT stocks.
Read Full
SP Group holds 18.37% of Tata Sons and owes ~₹60,000 crore. Fresh talks explore swapping ~7% for listed Tata shares. No deal yet - both sides remain divided on value. Here is the full picture: gross m
Read Full
FPIs bought ₹15,559 crore in Indian equities in the first fortnight of July 2026 — the second straight fortnight of net buying. Consumer services led at $765M, metals at $623M. Autos saw $721M selling
Read Full
Brent crossed $100 on July 24, 2026. The rupee hit ₹96.80. India has $675bn in reserves but a $106.6bn RBI forward short. Here is how oil, the rupee, and RBI policy pressure each other and where house
Read Full
India has identified $51 billion of imports across 100 products for domestic manufacturing. Mobile phones show what works. Solar shows what goes wrong. Here is why the 2030 opportunity depends on sequ
Read Full
Over $300 billion in global drug revenue loses exclusivity by 2030. India's generic base is well placed, but the real opportunity lies in complex generics, biosimilars, and API localisation. Here is w
Read Full